1. Sulfonyl modulators of serotonin 5-HT6 receptors and their pharmacophore models (Review). Ivachtchenko A.V. Russ. Chem. Rev. 2014, 83 (5), 439-473.
2. Small Molecule 5-HT6R Ligands: A Comprehensive Insight into their Selectivity and Activity (Review). Ivachtchenko A.V., Ivanenkov Y.A. Curr. Bioactiv. Comp. 2013, 9(1), 64-100.
3. 5-HT6 receptor modulators: a patent update. Part 1. Sulfonyl derivatives (Review). Ivachtchenko A.V., Ivanenkov Y.A. Expert Opin. Ther. Pat. 2012, 22(8), 917-964.
4. 5-HT6 receptor modulators: a patent update. Part 2. Diversity in heterocyclic scaffolds (Review). Ivachtchenko A.V., Ivanenkov Y.A., Skorenko A.V. Expert Opin. Ther. Pat. 2012, 22(10), 1123-1168.
5. 5-hydroxytryptamine subtype 6 receptor modulators: a patent survey. Ivachtchenko A.V., Ivanenkov Y.A., Tkachenko S.E. Expert Opin. Ther. Pat. 2010, 20(7), 1171-1196.
6. The synthesus and physiological activity of 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles (Review). Ivachtchenko A.V., Mitkin O.D., Kadieva ?.?., Tkachenko S.E. Russian Chem. Rev. 2010, 79(4), 285-306.
7. From anti-allergic to anti-Alzheimer’s: Molecular pharmacology of Dimebon. Okun I.M.; Tkachenko S.E.; Khvat A.V. at al. Curr. Alzheimer Res. 2010, 7(2), 97–112